Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-12-01

Clinical Trial Update: Generic Travoprost Versus Brand Name Travoprost in Patients With Primary Open Angle Glaucoma or Ocular Hypertension [Phase 4]

View source ↗

Summary

Phase 4 trial comparing generic travoprost to brand-name travoprost in primary open-angle glaucoma or ocular hypertension; results posted after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Travoprost (Travoprost (isomer-free))

Snippet

Sponsor: Université de Sherbrooke | Conditions: Glaucoma, Primary Open Angle, Ocular Hypertension | Phase 4 | Status: COMPLETED | Results posted: 2020-12-01